PRME
Prime Medicine
Stock NYSE Arca – Stock Market Prices, News & Analysis
Biotechnology company specializing in the development of gene therapies to treat rare genetic disorders.
$ 3.67
3.17 %
Prime Medicine
$
3.67
3.17 %
PRME
Biotechnology company specializing in the development of gene therapies to treat rare genetic disorders.
Price history of Prime Medicine
Price history of Prime Medicine
Performance & Momentum
6 Months
38.20 %
1 Year
200.00 %
3 Years
71.46 %
5 Years
77.73 %
Similar stocks to Prime Medicine
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
